Detection and treatment of mutations in a cd40 ligand gene

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 35/12 (2006.01) A61K 39/395 (2006.01) A61K 48/00 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01) C12N 15/85 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2153806

There is disclosed a method of detecting a mutation in a CD40 ligand gene, comprising isolating nucleic acid from an individual, selectively amplifying nucleic acid derived from the CD40 ligand gene, and analyzing the amplified nucleic acid to determine if there is a mutation (or mutations) in the CD40 ligand gene. The ability of a CD40 ligand protein expressed from the gene may be determined. Methods of treating a syndrome that results in elevated levels of serum IgM and diminished levels of all other isotypes of immunoglobulins are also disclosed. Also disclosed are non-human animals that lack functional CD40 ligand as a result of gene targeting technology.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Detection and treatment of mutations in a cd40 ligand gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection and treatment of mutations in a cd40 ligand gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and treatment of mutations in a cd40 ligand gene will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1447498

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.